Fresenius Kabi To Build ‘One Of The Largest Sterile Injectable Manufacturing Networks In US’
Alliance With Phlow Will Strengthen American Resilience To Public Health Crises
Stating the importance of the US sterile injectables market for Fresenius Kabi, Matt Kuhn, senior director of external communications, talks to Generics Bulletin about the company’s plans to build one of the largest sterile injectable manufacturing networks in America. Meanwhile Ali Ahmed, senior vice president of biosimilars at Fresenius Kabi in the US, talks about supply reliability in biosimilars.
